GOVX new logo.png
GeoVax Announces Issuance of Hepatitis B Vaccine Patent
July 07, 2021 09:00 ET | GeoVax, Inc.
Vaccine Would Address Therapeutic Medical Need of Over 250 Million Worldwide ATLANTA, GA, July 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX) (“GeoVax” or the...
IRB Logo.png
Human Vaccines Market and Vaccine Refrigerator Market Size 2020 Growing Rapidly with Modern Trends, Development Status, Investment Opportunities, Global Revenue, Demand, Trends and Forecast to 2026 Says Industry Research Biz
August 12, 2020 07:13 ET | Industry Research
Pune, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Global Human Vaccines Market 2020-2026: Global “Human Vaccines Market” Research Report 2020-2026 is a historical overview and in-depth study on the current...
GeoVax.png
GeoVax Publishes Ebola Vaccine Study Results in Nature’s Scientific Reports
January 16, 2018 09:00 ET | GeoVax, Inc.
ATLANTA, GA, Jan. 16, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced publication of its manuscript entitled “A...